TEVA PHARMACEUTICAL IND LTD
TEVANYSEEarnings Nov 3US Equity
$40.12▲ $1.28 (+3.19%)
LiveTrack TEVA
Get earnings, price moves & breaking news on Telegram
24h▲ 3.2%
7d—
14d—
30d—
ytd—
1y—
🏦Market Cap
$46.73B
Mid Cap
📈Revenue Growth (YoY)
+4.1%
Slowing
📊Gross Margin
52.9%
Healthy
💵FCF Margin
9.0%
Moderate
⚖️P/S Ratio
2.6x
Cheap
Otter Score
72
Fair
Earnings
Q3 · 2026Reported 2026-07-29Earnings Per Share
Actual
0.02
Expected
0.08
miss
−75.00%
YoY −97.00%
Revenue
Actual
$4.14B
Expected
$4.08B
beat
+1.50%
YoY −0.80%
Consensus estimates
Recent quarters
Q3 2026
0.02
miss
Q2 2026
0.53
beat
Q1 2026
0.96
beat
Q4 2025
0.78
beat